1228 related articles for article (PubMed ID: 8780392)
1. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
van Elsas A; Zerp SF; van der Flier S; Krüse KM; Aarnoudse C; Hayward NK; Ruiter DJ; Schrier PI
Am J Pathol; 1996 Sep; 149(3):883-93. PubMed ID: 8780392
[TBL] [Abstract][Full Text] [Related]
2. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.
Zerp SF; van Elsas A; Peltenburg LT; Schrier PI
Br J Cancer; 1999 Feb; 79(5-6):921-6. PubMed ID: 10070891
[TBL] [Abstract][Full Text] [Related]
3. Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.
Omholt K; Karsberg S; Platz A; Kanter L; Ringborg U; Hansson J
Clin Cancer Res; 2002 Nov; 8(11):3468-74. PubMed ID: 12429636
[TBL] [Abstract][Full Text] [Related]
4. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
[TBL] [Abstract][Full Text] [Related]
5. Detection of B-RAF and N-RAS mutations in human melanoma.
Goydos JS; Mann B; Kim HJ; Gabriel EM; Alsina J; Germino FJ; Shih W; Gorski DH
J Am Coll Surg; 2005 Mar; 200(3):362-70. PubMed ID: 15737846
[TBL] [Abstract][Full Text] [Related]
6. UV-induced N-ras mutations are T-cell targets in human melanoma.
van Elsas A; Scheibenbogen C; van der Minne C; Zerp SF; Keilholz U; Schrier PI
Melanoma Res; 1997 Aug; 7 Suppl 2():S107-13. PubMed ID: 9578425
[TBL] [Abstract][Full Text] [Related]
7. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
[TBL] [Abstract][Full Text] [Related]
8. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.
Jiveskog S; Ragnarsson-Olding B; Platz A; Ringborg U
J Invest Dermatol; 1998 Nov; 111(5):757-61. PubMed ID: 9804334
[TBL] [Abstract][Full Text] [Related]
9. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.
Poetsch M; Dittberner T; Cowell JK; Woenckhaus C
Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369
[TBL] [Abstract][Full Text] [Related]
10. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
11. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917
[TBL] [Abstract][Full Text] [Related]
12. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients.
Daya-Grosjean L; Robert C; Drougard C; Suarez H; Sarasin A
Cancer Res; 1993 Apr; 53(7):1625-9. PubMed ID: 8453633
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites.
Deichmann M; Krahl D; Thome M; Wüst K; Hassanzadeh J; Helmke B
Int J Oncol; 2006 Jul; 29(1):139-45. PubMed ID: 16773193
[TBL] [Abstract][Full Text] [Related]
14. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
15. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites.
Ananthaswamy HN; Price JE; Goldberg LH; Bales ES
Cancer Res; 1988 Jun; 48(12):3341-6. PubMed ID: 3370635
[TBL] [Abstract][Full Text] [Related]
16. ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development.
Shukla VK; Hughes DC; Hughes LE; McCormick F; Padua RA
Oncogene Res; 1989; 5(2):121-7. PubMed ID: 2691957
[TBL] [Abstract][Full Text] [Related]
17. Absence of ras gene mutations in UV-induced malignant melanomas correlates with a dermal origin of melanocytes in Monodelphis domestica.
Chan J; Robinson ES; Yeh IT; McCarrey JR
Cancer Lett; 2002 Oct; 184(1):73-80. PubMed ID: 12104050
[TBL] [Abstract][Full Text] [Related]
18. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma.
Demunter A; Stas M; Degreef H; De Wolf-Peeters C; van den Oord JJ
J Invest Dermatol; 2001 Dec; 117(6):1483-9. PubMed ID: 11886512
[TBL] [Abstract][Full Text] [Related]
19. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
20. N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
van 't Veer LJ; Burgering BM; Versteeg R; Boot AJ; Ruiter DJ; Osanto S; Schrier PI; Bos JL
Mol Cell Biol; 1989 Jul; 9(7):3114-6. PubMed ID: 2674680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]